TMC558445
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TMC558445, covering 2010-04-28 to 2010-04-28. Get the full timeline:
Most recent: Clinical Trial Update: PEPI-TiDP23-C103: First-in-Human Study to Examine the Safety, Tolerability, and Plasma Pharmacokinetics of Increasing Single and Repeated Oral Doses of TMC558445 and of a Combined Single Day Dosing of Oral TMC558445 and Oral TMC310911 and Also Oral Darunavir [Phase 1]